Cargando…
Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
The selection of patients eligible for implantable cardioverter defibrillator (ICD), in primary prevention, is a critical moment in the management of the patients with cardiomyopathies as it needs a right balance of the patients’ arrhythmic risk and the risks related to the implantation, as well as...
Autor principal: | Rizzello, Vittoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653128/ https://www.ncbi.nlm.nih.gov/pubmed/36380775 http://dx.doi.org/10.1093/eurheartjsupp/suac087 |
Ejemplares similares
-
Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible
por: Sciatti, Edoardo, et al.
Publicado: (2022) -
Association between heart and dementia… keep an eye on the left atrium
por: Terrosu, Pierfranco
Publicado: (2022) -
Treatment of amyloidosis: present and future
por: Mallus, Maria Teresa, et al.
Publicado: (2023) -
Implantable cardioverter defibrillators – the past, present and future
por: Ammannaya, Ganesh Kumar K.
Publicado: (2020) -
Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
por: Younis, Arwa, et al.
Publicado: (2023)